| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |